NCT05593172 is a clinical trial in Mild Traumatic Brain Injury, sponsored by Danderyd Hospital.

Who is sponsoring NCT05593172?

NCT05593172 is sponsored by Danderyd Hospital.

What condition does NCT05593172 study?

NCT05593172 studies Mild Traumatic Brain Injury.

Is NCT05593172 still recruiting?

NCT05593172 is currently completed. Last updated 25 October 2022.

Last reviewed 2022-10-25 · How we verify

NCT05593172

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Change in Connectivity After mTBI Depending on Cognitive Reserve

Completed Last updated 25 October 2022

What this trial tests

trial in Mild Traumatic Brain Injury in 30 participants. Completed in 3 May 2016.

Timeline

24 January 2015

Primary endpoint
3 May 2016

3 May 2016

Quick facts

Lead sponsor	Danderyd Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	30
Start date	24 January 2015
Primary completion	3 May 2016
Estimated completion	3 May 2016
Sites	1 location across Sweden

Conditions studied

Mild Traumatic Brain Injury — all drugs for Mild Traumatic Brain Injury →

Sponsor

Danderyd Hospital

Who can join

Adults 18 to 40, any sex, with Mild Traumatic Brain Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to investigate the role of cognitive reserve in change in connectivity in the brain (measured with functional magnetic resonance imaging, fMRI) and how this is related to symptoms and symptom resolution.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Investigating cognitive reserve, symptom resolution and brain connectivity in mild traumatic brain injury.
Ekdahl N, Möller MC, Deboussard CN, Stålnacke BM, et al · · 2023 · cited 9× · PMID 38124076 · DOI 10.1186/s12883-023-03509-8

Verify or expand the search:

Other recruiting trials for Mild Traumatic Brain Injury

Currently open trials in the same condition.

NCT07246993 — Targeting Neuroplasticity for Persistent Post-Concussive Cognitive Symptoms · NA · recruiting
NCT07356167 — Passive Neurosensory Reintegration Training as a Tool to Augment Mild Traumatic Brain Injury · NA · recruiting
NCT07097792 — Concussion Recovery and Support Program · NA · recruiting
NCT06956417 — REhabilitation of MEMory Symptoms After BRain Concussion · NA · recruiting
NCT06217575 — Brain Research Assessing Impacts of Neurophysiological Processing Speed Training in Veterans · NA · recruiting

Other Danderyd Hospital trials

Trials by the same sponsor.

NCT06275503 — STROKESTOP III - Optimized Method for Atrial Fibrillation Screening · NA · recruiting
NCT06346145 — Impact of Bariatric Surgery on Heart Disease Compared to Standard Care · NA · not yet recruiting
NCT07476703 — Expanded Studies on the SCAPIS Stockholm Reexamination Cohort · recruiting
NCT05359367 — A Novel Approach to Enhance True Recovery After Stroke · terminated
NCT06734247 — Arterial Stiffness for Improved Prediction of Coronary Artery Disease by Coronary CT Angiography · terminated

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05593172 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Danderyd Hospital
Last refreshed: 25 October 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05593172.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing